Ulcerative Colitis Stocks List

Ulcerative Colitis Stocks Recent News

Date Stock Title
Jul 1 ABBV 2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
Jul 1 ABBV AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
Jul 1 ABBV AbbVie names Robert A. Michael to CEO role
Jul 1 ABBV Robert A. Michael Assumes Role as AbbVie Chief Executive Officer
Jul 1 ABBV 3 Magnificent Stocks Retirees Can Buy and Hold Forever
Jul 1 ABBV 10 clinical trials to watch in the second half of 2024
Jun 29 ABBV How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
Jun 28 ABBV How Medicare drug price negotiations could hit pharma stocks
Jun 28 ABBV Coherus offloads Humira biosimilar Yusimry for $40m
Jun 28 PTGX Protagonist Therapeutics Surges On Plans To Join S&P SmallCap 600
Jun 28 ABBV AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
Jun 28 ABBV AbbVie, Genmab blood cancer therapy endorsed in EU
Jun 28 ABBV Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
Jun 28 ABBV AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
Jun 28 ABBV AbbVie completes acquisition of Celsius Therapeutics for $250m
Jun 28 PTGX Protagonist Therapeutics set to join S&P SmallCap 600
Jun 28 ABBV AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
Jun 27 PTGX Protagonist Therapeutics Set to Join S&P SmallCap 600
Jun 27 PTGX Is Protagonist Therapeutics, Inc. (PTGX) a Good Healthcare Stock to Buy?
Jun 27 ABBV FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
Ulcerative Colitis

Ulcerative colitis (UC) is a long-term condition that results in inflammation and ulcers of the colon and rectum. The primary symptoms of active disease are abdominal pain and diarrhea mixed with blood. Weight loss, fever, and anemia may also occur. Often, symptoms come on slowly and can range from mild to severe. Symptoms typically occur intermittently with periods of no symptoms between flares. Complications may include megacolon, inflammation of the eye, joints, or liver, and colon cancer.The cause of UC is unknown. Theories involve immune system dysfunction, genetics, changes in the normal gut bacteria, and environmental factors. Rates tend to be higher in the developed world with some proposing this to be the result of less exposure to intestinal infections, or to a Western diet and lifestyle. The removal of the appendix at an early age may be protective. Diagnosis is typically by colonoscopy with tissue biopsies. It is a kind of inflammatory bowel disease (IBD) along with Crohn's disease and microscopic colitis.Dietary changes, such as maintaining a high-calorie diet or lactose-free diet, may improve symptoms. Several medications are used to treat symptoms and bring about and maintain remission, including aminosalicylates such as mesalazine or sulfasalazine, steroids, immunosuppressants such as azathioprine, and biologic therapy. Removal of the colon by surgery may be necessary if the disease is severe, does not respond to treatment, or if complications such as colon cancer develop. Removal of the colon and rectum can cure the disease.Together with Crohn's disease, about 11.2 million people were affected as of 2015. Each year it newly occurs in 1 to 20 per 100,000 people, and 5 to 500 per 100,000 individuals are affected. The disease is more common in North America and Europe than other regions. Often it begins in people aged 15 to 30 years, or among those over 60. Males and females appear to be affected in equal proportions. It has also become more common since the 1950s. Together, ulcerative colitis and Crohn's disease affect about a million people in the United States. With appropriate treatment the risk of death appears the same as that of the general population. The first description of ulcerative colitis occurred around the 1850s.

Browse All Tags